Seems I am getting carried away with some possibil
Post# of 72440
In that all small drug (or otherwise) companies need money to grow and hopefully become profitable in their own right in time. Leo as we know been seeking a partner and has in the past issued stock to keep going.
Now because of COVID 19. a big change has occurred as we know. should IPIX get enough Grant money to get Brilacidin all the way through to full FDA APPROVAL that of course puts a big boost to the company WITHOUT the need of a partner. Revenues generated from Brilacidin should to enough not only to make IPIX a profitable going concern on its own but also able to fund and advance KEVETRIN which I still SEE as the BIG MONEY MAKING DRUG for IPIX. AND AGAIN ALL WITHOUT THE NEED OF A FINANCIAL PARTNER. May need a DISTRIBUTORS help but not a partner. IPIX keeps all the MONEY.
So how far off is my thinking here ? TIA